AXP
American Express Company
AXP has the edge over JPM overall, supported by stronger valuation and stronger modeled upside.
JPM
JPMorgan Chase & Co.
JPM offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AXP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
AXP's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like AXP.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
AXP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $276 | -13% |
| Forward | 16x | $318 | — |
| Current | 18x | $318 | — |
| Fair | 19x | $338 | +6.4% |
| Expensive | 23x | $407 | +28% |
Historical ranges are pointers, not guarantees.
AXP's PE is in its fair range at 18x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over AXP in the historical PE scenario, which offers more potential upside but is not a forecast.
AXP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
AXP has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
AXP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $19.38 | +9.2% |
| Q3 2026 | $17.75 | +19% |
| Q2 2026 | $16.47 | +16% |
| Q1 2026 | $16.02 | +12% |
| Q4 2025 | $15.38 | +9.8% |
| Q3 2025 | $14.90 | +9.6% |
| Q2 2025 | $14.25 | +6.3% |
| Q1 2025 | $14.32 | +18% |
| Q4 2024 | $14.01 | +25% |
AXP's earnings per share have climbed steadily: $17.75 over the past year, up 19% from the year before, and higher year over year for 14 quarters in a row.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over AXP on earnings, with stronger typical year-over-year growth.
AXP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.1B | +8.9% |
| Q2 2026 | $19.6B | +10% |
| Q1 2026 | $18.9B | +11% |
| Q4 2025 | $19B | +10% |
| Q3 2025 | $18.4B | +11% |
| Q2 2025 | $17.9B | +9.3% |
| Q1 2025 | $17B | +7.4% |
| Q4 2024 | $17.2B | +8.7% |
AXP has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +1.8 points |
| Q2 2026 | 21% | +0.9 points |
| Q1 2026 | 20% | +0.4 points |
| Q4 2025 | 16% | +0.2 points |
| Q3 2025 | 21% | +1.5 points |
| Q2 2025 | 20% | -3.3 points |
| Q1 2025 | 20% | -0.3 points |
| Q4 2024 | 16% | +0.1 points |
AXP's operating margin was 23% last quarter, up 1.8 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over AXP on profitability, with a higher operating margin.
AXP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.4B | -20% |
| Q2 2026 | $4.5B | +19% |
| Q1 2026 | $2.7B | -39% |
| Q4 2025 | $2.3B | -56% |
| Q3 2025 | $5.6B | +$7.8B |
| Q2 2025 | $3.7B | -5.6% |
| Q1 2025 | $4.3B | -16% |
| Q4 2024 | $5.3B | -17% |
AXP has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
AXP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -5M shares |
| 1 year | -2.7% | -19M shares |
| 3 years | -8% | -59M shares |
| 5 years | -14% | -113M shares |
| Available history | -19% | -156M shares |
AXP has 674M diluted shares, down 2.7% from a year ago, with $6.7B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.6B |
| Q2 2026 | $2.3B |
| Q1 2026 | $1.9B |
| Q4 2025 | $899M |
| Q3 2025 | $2.4B |
| Q2 2025 | $1.4B |
| Q1 2025 | $1.2B |
| Q4 2024 | $1B |
AXP spent $6.7B buying back its own shares over the past year, up 13% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over AXP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
AXP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.3x | Elevated |
| Q1 2026 | 3.6x | Elevated |
| Q4 2025 | 3.5x | Elevated |
| Q3 2025 | 3.7x | Elevated |
| Q2 2025 | 3.9x | Elevated |
| Q1 2025 | 3.4x | Elevated |
| Q4 2024 | 3.3x | Elevated |
AXP's net debt is about 3.2 years of its operating earnings (EBITDA), down from 3.7 years a year ago. Net leverage isn't a meaningful measure for financial services companies like AXP.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over AXP on leverage, with a lower net debt burden relative to earnings.
AXP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 41.5 | Neutral |
AXP's weekly RSI is 47 (neutral) and its Stochastic is 41 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
AXP PE vs Financial Services Sector
| Metric | AXP | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 38% above |
| PE % | 36 | 63 | 27 pts below |
AXP is trading at 18x earnings, a 38% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over AXP on valuation relative to its sector.
AXP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $313.1 | 1.6% above |
| 20 week MA | $327.0 | 2.7% below |
| 50 week MA | $331.4 | 4% below |
| 100 week MA | $319.7 | 0.5% below |
| 200 week MA | $261.5 | 22% above |
AXP's trend is mixed: it's above two of its five weekly moving averages, and 22% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over AXP on trend strength, trading above more of its moving averages.
AXP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $125.2 | $117.4 | -6.3% |
| 2021 | $117.4 | $164.2 | +40% |
| 2022 | $164.2 | $147.0 | -10% |
| 2023 | $147.0 | $187.3 | +27% |
| 2024 | $187.3 | $301.1 | +61% |
| 2025 | $301.1 | $381.1 | +27% |
| 2026 YTD | $381.1 | $318.1 | -17% |
AXP has finished higher in four of the last six years. It's down 17% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over AXP on returns for 2026, with the stronger performance.